Cabaletta Bio (CABA) Short-term Investments (2020 - 2025)

Cabaletta Bio has reported Short-term Investments for 6 years, with the latest figure at $50.6 million in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments changed N/A year-over-year to $50.6 million; the trailing twelve-month figure through Dec 2025 stood at $50.6 million (changed N/A YoY), and the FY2025 full-year result was $50.6 million, changed N/A from the prior year.
• Short-term Investments for Q4 2025 stood at $50.6 million, down from $99.7 million in the prior quarter.
• The five-year high for Short-term Investments was $99.7 million in Q3 2025, with the low at $1.0 million in Q3 2021.
• Average Short-term Investments over 5 years is $36.8 million, with a median of $48.1 million recorded in 2023.
• Year-over-year, Short-term Investments sank 87.6% in 2021 and jumped 2373.2% in 2022.
• Tracing CABA's Short-term Investments over 5 years: stood at $1.0 million in 2021, then jumped by 2394.0% to $24.9 million in 2022, then soared by 92.51% to $48.0 million in 2023, then slumped by 74.16% to $12.4 million in 2024, then soared by 308.07% to $50.6 million in 2025.
• The last three Short-term Investments figures came in at $50.6 million (Q4 2025), $99.7 million (Q3 2025), and $49.1 million (Q2 2025), per Business Quant data.

Peer Comparison